pyrrolidine dithiocarbamate has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-El-Fattah, MA; Abdelakader, NF; Zaki, HF | 1 |
| Jiang, W; Zhang, J; Zuo, Z | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Cognition Disorders
| Article | Year |
|---|---|
Pyrrolidine dithiocarbamate protects against scopolamine-induced cognitive impairment in rats.
Topics: Alzheimer Disease; Animals; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Dopamine; Glutathione; Hippocampus; Interleukin-10; Interleukin-1beta; Male; Neuroprotective Agents; Norepinephrine; Pyrrolidines; Rats; Rats, Wistar; Scopolamine; Serotonin; Thiocarbamates | 2014 |
Pyrrolidine dithiocarbamate attenuates surgery-induced neuroinflammation and cognitive dysfunction possibly via inhibition of nuclear factor κB.
Topics: Anesthetics; Animals; Buprenorphine; Carotid Arteries; Cognition Disorders; Conditioning, Psychological; Encephalitis; Fear; Hippocampus; Male; Matrix Metalloproteinase 9; Maze Learning; Neuroprotective Agents; NF-kappa B; Postoperative Complications; Propofol; Pyrrolidines; Rats; Rats, Inbred F344; Thiocarbamates | 2014 |